İçeriğe geç
akaturk Akademik ölçüm

Ufuk Avrupa · Horizon Europe (HORIZON)

Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

HORIZON-MISS-2027-02-CANCER-02 Supporting the implementation of the Cancer Mission HORIZON-IA Akademisyen

Son başvuru16 Eylül 2027 henüz açılmadı
Açılış10 Şubat 2027AB verisi
DurumYakındagüncelleme 3 Ekim 2026

Çağrı özeti

Resmi metinden, ilk bölüm

Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: Patients afflicted by lung, bowel, breast or prostate cancer [1] , will benefit from the outcomes of evidence-based, tailored, innovative, affordable and accessible diagnosis- and treatment-centred clinical research programmes by comprehensive cancer infrastructures [2] . Researchers, physicians, patient representatives, civil society, charities, foundations, insurance companies, SMEs and innovators [3] will seize opportunities to respectively co-create, support, upscale or commercialise outcomes of evidence-based, tailored, affordable and accessible clinical research programmes for the diagnosis and treatment of patients afflicted by lung, bowel, breast or prostate cancer. National and regional healthcare providers, … devamı

Anticancer therapyClinical medicineDigital dataGender in basic medicinePersonalised medicineRadiology, nuclear medicine and medical imagingTranslational medicineCancer centreClinical Trial CentreComprehensive Cancer CentreDiagnostic facilitiesHospitalMedical CentreOncology Department

İlgili olabilecek akademisyenler

Konu uyumuna göre

30
  1. %71
    MEHMET ENES DEĞİRMENCİ
    Doktor Öğretim ÜyesiDemiroğlu Bilim Üniversitesi

    Ortak konular: Bladder and Urothelial Cancer Treatments · Prostate Cancer Diagnosis and Treatment · Prostate Cancer Treatment and Research

    Örtüşen yayınlar: The diagnostic accuracy of Ga68 PSMA PET-CT on clinical lymph node staging before radical prostatectomy in patients with intermediate or high risk prostate cancer (2020) · Impact of delay in cystoscopic surveillance on recurrence and progression rates in patients with non-muscle-invasive bladder cancer during the COVID-19 pandemic. (2021)

  2. %70
    TANER KORKMAZ
    ProfesörAcıbadem Mehmet Ali Aydınlar Üniversitesi

    Ortak konular: Lung Cancer Treatments and Mutations · Lung Cancer Research Studies · Advanced Breast Cancer Therapies · Lung Cancer Diagnosis and Treatment

  3. %70
  4. %68
    ALİ ÖZÇAĞLAYAN
    Araştırma GörevlisiOndokuz Mayıs Üniversitesi

    Ortak konular: COVID-19 Clinical Research Studies · Ovarian cancer diagnosis and treatment

  5. %67
    ERCAN KARAARSLAN
    ProfesörAcıbadem Mehmet Ali Aydınlar Üniversitesi

    Ortak konular: Prostate Cancer Diagnosis and Treatment · MRI in cancer diagnosis · Prostate Cancer Treatment and Research

  6. %67
    GIORGIO IVAN RUSSO
    DOKTOR (Kısmi Zamanlı, Yurt Dışı)Biruni Üniversitesi

    Ortak konular: Bladder and Urothelial Cancer Treatments · Prostate Cancer Diagnosis and Treatment · Prostate Cancer Treatment and Research

    Örtüşen yayınlar: Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach (2025) · GPT-4 generates accurate and readable patient education materials aligned with current oncological guidelines: A randomized assessment (2025)

  7. %65
    ECE ESİN
    ProfesörAtılım Üniversitesi

    Ortak konular: Colorectal Cancer Treatments and Studies · Cancer Treatment and Pharmacology · Breast Cancer Treatment Studies

    Örtüşen yayınlar: Well differentiated neuroendocrine tumors, a single center experience (2018) · Prognostic value of ABO blood group in patients with nonseminomatous testicular cancer who treated with autologous stem cell transplantation (2018)

  8. %65
    HACER DEMİR
    DoçentAfyonkarahisar Sağlık Bilimleri Üniversitesi

    Ortak konular: Advanced Breast Cancer Therapies · Breast Cancer Treatment Studies · HER2/EGFR in Cancer Research · Colorectal Cancer Treatments and Studies

    Örtüşen yayınlar: A New Prognostic Index in Young Breast Cancer Patients (2021) · Effect of systemic immune-inflammation index on prognostic parameters and survival in patients with breast cancer under the age of 40 years (2021)

  9. %64
    DAVUT ŞAHİN
    DoçentAcıbadem Mehmet Ali Aydınlar Üniversitesi

    Ortak konular: Cancer and biochemical research · Cervical Cancer and HPV Research

    Örtüşen yayınlar: Yüksek Risk HPV Pozitif, PAP Testi Negatif Vakalarda İlave Bir Sıvı Bazlı Sitoloji Preperatının Sitolojik Tanıya Etkisi (2019) · Should pancreas cyst fluids be divided into two for cytological diagnosis and biochemical tests? (2019)

  10. %64
    FATİH KEMİK
    Araştırma GörevlisiKoç Üniversitesi

    Ortak konular: Prostate Cancer Treatment and Research · HER2/EGFR in Cancer Research · Advanced Breast Cancer Therapies · Prostate Cancer Diagnosis and Treatment

  11. %64
    YEŞİM ERALP
    ProfesörAcıbadem Mehmet Ali Aydınlar Üniversitesi

    Ortak konular: Breast Cancer Treatment Studies · Advanced Breast Cancer Therapies · Lung Cancer Treatments and Mutations · HER2/EGFR in Cancer Research

    Örtüşen yayınlar: The Role of Genomic Profiling in Advanced Breast Cancer The Two Faces of Janus (2016) · A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy. (2024)

  12. %63
  13. %62
  14. %62
    ÖMER TOPDAĞI
    DoçentBahçeşehir Üniversitesi

    Ortak konular: Colorectal Cancer Screening and Detection · Colorectal Cancer Surgical Treatments

    Örtüşen yayınlar: Demographic and Clinical Characteristics of Patients Diagnosed with Colorectal Cancer: Six-Year Experience (2020) · Unusual variants of primary malignant esophageal tumors (2016)

  15. %62
    ÖZLEM ERCELEP
    ProfesörBahçeşehir Üniversitesi

    Ortak konular: Lung Cancer Treatments and Mutations · Lung Cancer Diagnosis and Treatment

    Örtüşen yayınlar: Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer (2016) · PTK-7 Expression in Gastric Cancer: A Prognostic Determinant (2020)

  16. %61
  17. %61
    TUĞBA AKIN TELLİ
    DoçentDemiroğlu Bilim Üniversitesi

    Ortak konular: Lung Cancer Treatments and Mutations · Lung Cancer Diagnosis and Treatment · Colorectal Cancer Treatments and Studies · Lung Cancer Research Studies

    Örtüşen yayınlar: Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel (2020) · Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (≥75) patients (2021)

  18. %59
    EBUBEKİR DİRİCAN
    DoçentBilecik Şeyh Edebali Üniversitesi

    Ortak konular: COVID-19 Clinical Research Studies · PI3K/AKT/mTOR signaling in cancer

    Örtüşen yayınlar: PIK3CA and TP53 MUTATIONS and SALL4, PTEN and PIK3R1 GENE EXPRESSION LEVELS in BREAST CANCER (2020) · Functional and clinical significance of SALL4 in breast cancer (2016)

  19. %59
  20. %59
    MERVA AYDEMİR AKKAYA
    Doktor Öğretim ÜyesiVan Yüzüncü Yıl Üniversitesi

    Ortak konular: Prostate Cancer Diagnosis and Treatment · Breast Cancer Treatment Studies

    Örtüşen yayınlar: Comparison of Gleason scoring and the new Grade-Group System in prostate cancers: a 15-year retrospective study (2020) · Non-Sebasöz Lenfadenoma: Nadir Görülen Bir Tükrük Bezi Tümörü (2020)

  21. %59
    NİYAZİ VOLKAN DEMİRCAN
    Doktor Öğretim ÜyesiBahçeşehir Üniversitesi

    Ortak konular: Breast Cancer Treatment Studies · Lung Cancer Diagnosis and Treatment

    Örtüşen yayınlar: Evaluation of helical tomotherapy as an alternative for left-sided breast cancer patients not compliant with deep inspiration breath hold (2024) · New Approaches in Breast Cancer Radiotherapy (2024)

  22. %58
    GÖKHAN AYDIN
    Öğretim Görevlisi (ders Vermekle Görevli)Acıbadem Mehmet Ali Aydınlar Üniversitesi

    Ortak konular: Lung Cancer Diagnosis and Treatment · Prostate Cancer Diagnosis and Treatment

    Örtüşen yayınlar: Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation (2020) · Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors (2020)

  23. %58
    HATİCE GÖZDE KESKİN
    Öğretim Görevlisi (ders Vermekle Görevli)Ankara Medipol Üniversitesi

    Ortak konular: Cervical Cancer and HPV Research

    Örtüşen yayınlar: Vulva Cancer and Nursing Approaches After Vulvectomy (2021)

  24. %58
    İSMAİL NECİM YÜCEL
    Araştırma GörevlisiYeditepe Üniversitesi

    Ortak konular: Cholangiocarcinoma and Gallbladder Cancer Studies

  25. %57
  26. %57
  27. %57
    HACI MEHMET TÜRK
    ProfesörBezm-İ Âlem Vakıf Üniversitesi

    Ortak konular: Lung Cancer Treatments and Mutations · Gastric Cancer Management and Outcomes · Colorectal Cancer Treatments and Studies · Lung Cancer Research Studies

    Örtüşen yayınlar: Successful retreatment with erlotinib after erlotinib-related interstitial lung disease. (2021) · First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer. (2022)

  28. %57
    PIRILTI ÖZCAN
    Doktor Öğretim ÜyesiBiruni Üniversitesi

    Ortak konular: Ovarian cancer diagnosis and treatment · Gastric Cancer Management and Outcomes · Colorectal Cancer Surgical Treatments

    Örtüşen yayınlar: The Role of Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in Recurrent Ovarian Peritoneal Carcinomatosis (2024) · The Role of Diagnostic Laparoscopy in Staging and Treatment Planning of Gastric Cancer: A 400-Patient Retrospective Cohort Study (2026)

  29. %57
    SERCAN ÖZKAÇMAZ
    DoçentVan Yüzüncü Yıl Üniversitesi

    Ortak konular: Lung Cancer Diagnosis and Treatment · COVID-19 Clinical Research Studies

    Örtüşen yayınlar: Radiological tips on safe tract selection in computed tomography-guided transthoracic biopsy: single-center results (2024) · Deep learning in distinguishing pulmonary nodules as benign and malignant (2024)

  30. %57
    VELİ MERT YAZAR
    DoçentAfyonkarahisar Sağlık Bilimleri Üniversitesi

    Ortak konular: Prostate Cancer Diagnosis and Treatment · Bladder and Urothelial Cancer Treatments · Prostate Cancer Treatment and Research

    Örtüşen yayınlar: Clinical Comparison of Hematuria Degree and Pathology According to the AUA Bladder Cancer Risk Classification (2025) · The Effect of Lymphovascular Invasion on Short-Term Tumor Recurrence and Progression in Stage T1 Bladder Cancer (2024)

Uyum oranı kodla, her istekte hesaplanır. Çağrı metni (başlık, anahtar kelimeler, resmi açıklamanın başı) şu üç kaynakla karşılaştırılır: akademisyen profiliyle anlamsal yakınlık (%50), YÖKSİS anahtar kelimeleri ve OpenAlex konularındaki ortak ayırt edici terimler (%25) ve yayın içeriği — başlıklar, İngilizce özetler ve bunların Türkçe çevirileri (%25). Çeviriler sayesinde Türkçe çağrılar İngilizce yayınlarla da eşleşir. Yaygın kelimeler düşük ağırlıklıdır; %40 altı gösterilmez. Bir konu önerisidir; başvuru uygunluğu, kapasite ya da başarı değerlendirmesi değildir. Gizli profiller listelenmez.